Gregory N. Fuller

University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuropathology

TX

United States

SCHOLARLY PAPERS

1

DOWNLOADS

39

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Window-of-Opportunity Clinical Trial of Pembrolizumab in Recurrent Glioblastoma (GBM) Patients

Number of pages: 99 Posted: 14 Oct 2018
University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, Baylor University, College of Medicine, Department of Neurology, University of Texas at Houston - Department of Biostatistics, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuropathology, University of Texas at Houston - Department of Pathology, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Radiology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology and University of Texas at Houston - Department of Neurosurgery
Downloads 39 (860,644)

Abstract:

Loading...

glioblastoma, immune checkpoint inhibitor, clinical trial, PD-1